Human Siglec-6/CD327 PE-conjugated Antibody Summary
Gln27-Val331
Accession # NP_942142
Customers also Viewed
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
View Larger
Detection of Siglec‑6/CD327 in U937 Human Cell Line by Flow Cytometry. U937 human histiocytic lymphoma cell line was stained with Mouse Anti-Human Siglec‑6/CD327 PE‑conjugated Monoclonal Antibody (Catalog # FAB2859P, filled histogram) or isotype control antibody (open histogram). View our protocol for Staining Membrane-associated Proteins.
View Larger
Detection of Siglec‑6/CD327 in Human PBMC lymphocytes by Flow Cytometry. Human peripheral blood mononuclear cell (PBMC) lymphocytes were stained with Mouse Anti-Human CD19 APC-conjugated Monoclonal Antibody (Catalog # FAB4867A) and either (A) Mouse Anti-Human Siglec-6/CD327 PE-conjugated Monoclonal Antibody (Catalog # FAB2859P) or (B) Mouse Phycoerythrin Isotype Control. View our protocol for Staining Membrane-associated Proteins.
Preparation and Storage
- 12 months from date of receipt, 2 to 8 °C as supplied.
Background: Siglec-6/CD327
Siglecs (Sialic acid binding Ig-like Lectins) are I-type (Ig-type) lectins that belong to the Ig superfamily. They are characterized by an N-terminal Ig-like V-type domain which mediates sialic acid binding, followed by varying numbers of Ig-like C2-type domains (1-4). Eleven human Siglecs (Siglec-1 through 11) have been cloned and characterized. Within these eleven, there are at least two groups, one of which is termed the CD33-related group. CD33-related Siglecs include CD33/Siglec-3 and Siglec-5 through 11 (1, 3). To date, no Siglec has been shown to recognize any cell surface ligand other than sialic acid. This suggests that interactions with glycans containing this carbohydrate are important in mediating the biological functions of Siglecs. The cDNA of human Siglec-6 (also known as OB-BP1 and CD33L), encodes a putative 442 amino acid (aa) protein that contains a 15 aa signal peptide, a 321 aa extracellular region, a 21 aa transmembrane region (TM), and an 85 aa cytoplasmic tail (5, 6). The extracellular region contains one N-terminal V-type Ig-like domain followed by two Ig-like C2-type domains. The cytoplasmic domain has one immunoreceptor tyrosine-based inhibition motif (ITIM). At least three additional isoforms exist, all of which encode an additional 11 aa’s at the N-terminus, likely due to the utilization of an alternate start site. Two of the three isoforms also show splicing. One isoform shows a 16 aa in-frame deletion in the second C2-like domain, while the other shows a deletion of the TM and cytoplasmic region, thus potentially generating a soluble form (6-9). Siglec-6 is found on B cells and in placenta, and would seem to have a restricted specificity for the sialyl Tn antigen (6, 10).
- Crocker, P.R. and J. Zhang (2002) Biochem. Soc. Symp. 69:83.
- Crocker, P.R. and A. Varki (2001) Immunology 103:137.
- Crocker, P.R. (2002) Curr. Opin. Struct. Biol. 12:609.
- Powell, L.D. and A. Varki (1995) J. Biol. Chem. 270:14243.
- Takei, Y. et al. (1997) Cytogenet. Cell Genet. 78:295.
- Patel, N. et al. (1999) J. Biol. Chem. 274:22729.
- GenBank Accession # NP_942143.
- GenBank Accession # NP_942142.
- GenBank Accession # NP_001236.
- Crocker, P.R. and A. Varki (2001) Trends Immunol. 22:337.
Product Datasheets
Citations for Human Siglec-6/CD327 PE-conjugated Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
4
Citations: Showing 1 - 4
Filter your results:
Filter by:
-
Controlled adsorption of multiple bioactive proteins enables targeted mast cell nanotherapy
Authors: Du, F;Rische, CH;Li, Y;Vincent, MP;Krier-Burris, RA;Qian, Y;Yuk, SA;Almunif, S;Bochner, BS;Qiao, B;Scott, EA;
Nature nanotechnology
Species: Human
Sample Types: BALF
Applications: Flow Cytometry -
Transitional dendritic cells are distinct from conventional DC2 precursors and mediate proinflammatory antiviral responses
Authors: Sulczewski, FB;Maqueda-Alfaro, RA;Alcántara-Hernández, M;Perez, OA;Saravanan, S;Yun, TJ;Seong, D;Arroyo Hornero, R;Raquer-McKay, HM;Esteva, E;Lanzar, ZR;Leylek, RA;Adams, NM;Das, A;Rahman, AH;Gottfried-Blackmore, A;Reizis, B;Idoyaga, J;
Nature immunology
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Bioactive multi-protein adsorption enables targeted mast cell nanotherapy
Authors: F Du, C Rische, Y Li, M Vincent, R Krier-Burr, Y Qian, S Yuk, S Almunif, B Bochner, B Qiao, E Scott
Research square, 2023-01-26;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Chromatin Landscape Underpinning Human Dendritic Cell Heterogeneity
Authors: R Leylek, M Alcántara-, JM Granja, M Chavez, K Perez, OR Diaz, R Li, AT Satpathy, HY Chang, J Idoyaga
Cell Rep, 2020-09-22;32(12):108180.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human Siglec-6/CD327 PE-conjugated Antibody
There are currently no reviews for this product. Be the first to review Human Siglec-6/CD327 PE-conjugated Antibody and earn rewards!
Have you used Human Siglec-6/CD327 PE-conjugated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
